companies aim-immunotech-inc 
Law 360
AUGUST 1, 2022
An investor has sued biopharmaceutical company AIM ImmunoTech Inc. and its three-member board in Delaware Chancery Court, claiming they unfairly prevented him from nominating new blood to join the company's brass.
Law 360
SEPTEMBER 16, 2022
BakerHostetler urged the Delaware Chancery Court on Friday to reject biopharmaceutical company AIM ImmunoTech Inc.'s s request for it to turn over documents in litigation over an alleged entrenchment effort by the company's board, calling the bid an "attempt to circumvent well-established case law precedent."
Law 360
SEPTEMBER 19, 2022
BakerHostetler and Potter Anderson & Corroon have traded barbs over a now vacated motion to compel filed by AIM ImmunoTech Inc. in a Delaware Chancery Court case over an alleged entrenchment effort by its board, with BakerHostetler saying the biopharmaceutical company may deserve sanctions for bad litigation behavior.
Expert insights. Personalized for you.
40 
Let's personalize your content